Intravenous Antibiotic Treatment at Home
ConditionInfection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHelse Møre og Romsdal HF
About this trial
The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the municipality and the hospital. This model will first be tested for use in intravenous antibiotic therapy. The results of the study will be used to further develop the service. In the larger context, it is desirable to provide knowledge that is transferable to other diagnostic groups, treatment methods and geographical areas.
Eligibility criteria
Qualifiers
Competent to give consent
The infection can not be treated with oral antibiotics in monotherapy
Selected IV antibiotics must be suitable for administration via selected pumps
The patient's condition is stable and does not require frequent observation by health care professionals
Disqualifiers
consent not given
Trial design
Treatments tested in this trial
- A new model of interaction across health services with use of welfare technology and telemedicine
Treatment groups
50 Participants
are divided into 3 treatment groupsSponsors and collaborators
Helse Møre og Romsdal HF
Lead sponsor
SINTEF Health Research
Collaborator
Kristiansund municipality
Collaborator
Centre for Health Innovation
Collaborator
Hospital Pharmacy of Central Norway Trust
Collaborator
Source ClinicalTrials.gov